SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Millions of men could benefit from faster scan to diagnose prostate cancer

2.

Older Adults With Advanced Cancer Prioritize Quality of Life

3.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

4.

Patients with head and neck cancer who cannot receive cisplatin now have new hope.

5.

Breast cancer screening in women's 40s can save lives, study says


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot